Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 USD | -1.56% | +15.43% | +22.85% |
09/05 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
01/04 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.85% | 7.71Cr | |
+7.64% | 11TCr | |
+10.40% | 11TCr | |
+0.41% | 2.23TCr | |
-11.88% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-5.08% | 1.72TCr | |
+6.52% | 1.43TCr | |
+36.23% | 1.25TCr |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- Canaccord Genuity Adjusts Price Target on Atara Biotherapeutics to $20 From $50, Maintains Buy Rating